HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stéphane De Wit Selected Research

Liver Transplantation

1/2016Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stéphane De Wit Research Topics

Disease

8Infections
05/2022 - 06/2013
7Acquired Immunodeficiency Syndrome (AIDS)
04/2024 - 03/2011
6Neoplasms (Cancer)
07/2023 - 06/2009
5HIV Infections (HIV Infection)
01/2023 - 01/2014
4Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 01/2014
3Weight Gain
04/2024 - 01/2023
3COVID-19
01/2022 - 07/2021
2Yellow Fever
01/2023 - 12/2022
2Viremia
01/2023 - 01/2017
2Myocardial Infarction
01/2018 - 06/2015
2Coinfection
01/2015 - 03/2013
1Hypertension (High Blood Pressure)
04/2024
1Hypersensitivity (Allergy)
12/2021
1Tetanus
01/2021
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2021
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2021
1Chronic Disease (Chronic Diseases)
11/2020
1Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2018
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2018
1Stroke (Strokes)
01/2018
1Squamous Intraepithelial Lesions
02/2017
1Hyponatremia
01/2017
1End Stage Liver Disease
01/2016
1Hepatic Encephalopathy
01/2016
1Hemorrhage
01/2016
1Hepatorenal Syndrome
01/2016
1Hepatocellular Carcinoma (Hepatoma)
01/2016
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
12/2015
1Ulcer
06/2015
1HIV Seropositivity
01/2014
1Hepatitis B
03/2013
1Latent Infection
06/2009
1Neurosyphilis (General Paresis of the Insane)
03/2007
1Neurologic Manifestations (Neurological Manifestations)
03/2007

Drug/Important Bio-Agent (IBA)

4IntegrasesIBA
04/2024 - 12/2021
3VaccinesIBA
01/2023 - 01/2021
3Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 01/2015
2antineoplaston A10 (A 10)IBA
01/2023 - 01/2023
2remdesivirIBA
12/2021 - 07/2021
2RNA (Ribonucleic Acid)IBA
01/2021 - 12/2016
2Anti-HIV Agents (AIDS Drugs)IBA
01/2016 - 03/2013
2prostratinIBA
07/2012 - 06/2009
2Histone Deacetylase InhibitorsIBA
07/2012 - 06/2009
1tenofovir alafenamideIBA
04/2024
1insulin receptor-related receptor (IRR)IBA
04/2024
1LipidsIBA
04/2024
1imidazole mustard (BIC)IBA
01/2023
1RacivirIBA
01/2023
1abacavir (Ziagen)FDA Link
01/2023
1Neutralizing AntibodiesIBA
01/2023
1InflammasomesIBA
01/2023
1ChromatinIBA
05/2022
1Integrase InhibitorsIBA
03/2022
1cilgavimab and tixagevimab drug combinationIBA
01/2022
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2022
1cilgavimabIBA
01/2022
1tixagevimabIBA
01/2022
1Oxygen (Dioxygen)IBA
12/2021
1Antiviral Agents (Antivirals)IBA
12/2021
1CobicistatIBA
01/2021
1elvitegravirIBA
01/2021
1Emtricitabine (Emtriva)FDA Link
01/2021
1Tenofovir (Viread)FDA Link
01/2021
1TabletsIBA
01/2021
1Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine Cobicistat ElvitegravirIBA
01/2021
1carbapenemaseIBA
11/2020
1Amoxicillin (Wymox)FDA LinkGeneric
01/2018
1Meropenem (Merrem)FDA LinkGeneric
01/2018
1NucleosidesIBA
01/2018
1Protease Inhibitors (Protease Inhibitor)IBA
01/2018
1Darunavir (Prezista)FDA Link
01/2018
1Atazanavir Sulfate (Reyataz)FDA Link
01/2018
1Reverse Transcriptase InhibitorsIBA
01/2018
1ritonavir drug combination atazanavirIBA
01/2018
1Ritonavir (Norvir)FDA Link
01/2018
1Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric
01/2018
1BilirubinIBA
01/2018
1ElectrolytesIBA
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2016
1Fetal Proteins (Fetoprotein)IBA
01/2016
1Didanosine (Videx)FDA LinkGeneric
01/2016
1Stavudine (Zerit)FDA LinkGeneric
01/2016
1MacrolidesIBA
12/2015
1Thalidomide (Thalomid)FDA Link
06/2015
1VorinostatFDA Link
07/2012
11,2,3,5,6,7- hexahydro- 7- methyl- 8- (4- tolylsulfinyl)- 5- indolizinoneIBA
07/2012
1NF-kappa B (NF-kB)IBA
06/2009
1ReaginsIBA
03/2007

Therapy/Procedure

8Therapeutics
04/2024 - 01/2016
7Art Therapy
04/2024 - 01/2014
4Highly Active Antiretroviral Therapy (HAART)
01/2021 - 03/2011
1Carotid Endarterectomy
01/2018
1Liver Transplantation
01/2016
1Retention in Care
01/2014